Unconjugated Human HLA-A*02:01 & B2M & NY-ESO-1 (SLLMWITQV) Complex Protein (Monomer, MALS verified)
Biozol Catalog Number:
ABS-HL1-H52T3-25UG
Supplier Catalog Number:
HL1-H52T3-25ug
Alternative Catalog Number:
ABS-HL1-H52T3-25UG
Manufacturer:
AcroBiosystems
Host:
Human
Category:
Proteine/Peptide
Species Reactivity:
Human
Conjugation:
Unconjugated
NYESO1, which is also wellknown as New York esophageal squamous cell carcinoma 1, is an efficient target for cancer immunotherapy. This antigen is a member of cancertestis antigens (CTAs) and is highly expressed in various cancers, including melanoma, ovarian, cervical cancer, etc. Adoptive T cell therapy with HLAA2 restricted NYESO1 transduced CD8+ T cells has improved the clinical response rates and overall survival of treatmentrefractory melanoma patients. The Human HLAA*0201 NYESO1 (SLLMWITQV) complex protein is a complex of HLAA*0201 of the MHC Class I, B2M and SLLMWITQV peptide of the NYESO1. - Proteine/Peptide
